(5-Bromopyridin-3-yl)(3-hydroxypiperidin-1-yl)methanone

Catalog No.: 
ACOPJT583
CAS No.: 
1157107-55-5
Molecular Formula: 
C11H13BrN2O2
Molecular Weight: 
285.14
(5-Bromopyridin-3-yl)(3-hydroxypiperidin-1-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$382.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5-Bromopyridin-3-yl)(3-hydroxypiperidin-1-yl)methanone
IUPAC Name(5-bromopyridin-3-yl)(3-hydroxypiperidin-1-yl)methanone
Molecular FormulaC11H13BrN2O2
Molecular Weight285.14
SMILESO=C(C1=CC(Br)=CN=C1)N2CC(O)CCC2
InChI KeyVYENMQYDJNKYOE-UHFFFAOYSA-N
Synonym(5-Bromo-pyridin-3-yl)-(3-hydroxy-piperidin-1-yl)-methanone;Methanone, (5-bromo-3-pyridinyl)(3-hydroxy-1-piperidinyl)-
CAS No.1157107-55-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOPJT583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSRBL984 route compound structure diagram
    ACSRBL98420826-04-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOPJT583 route product structure diagram
    ACOPJT5831157107-55-5
Inquiry

2. ACOPJT583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLCNP129 route compound structure diagram
    ACLCNP12939620-02-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOPJT583 route product structure diagram
    ACOPJT5831157107-55-5
Inquiry

3. ACOPJT583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOPJT583 route product structure diagram
    ACOPJT5831157107-55-5
Inquiry

Comments (0)